Show simple item record Belzil, Camille 2010-05-05T20:47:53Z 2010-05-05T20:47:53Z 2007-12
dc.identifier.issn 1718-8482
dc.description.abstract The Human Immunodeficiency Virus (HIV) is as simple as it is successful. Consisting of only relatively few elementary molecules, it is exceedingly hard to detect and has proven both difficult and expensive to treat. Treatment modalities are limited by the simplicity of its life cycle and the already compromised immune systems of patients. Current antiretroviral treatments are reasonably effective, but far too expensive for widespread distribution. Similarly, education can only go so far in combating such a virulent disease that is infectious in the absence of symptoms. This scenario presents an epidemiological dilemma: The highest rates of HIV prevalence are in underdeveloped and uneducated parts of the world. The areas worst afflicted lack the finances and infrastructure to initiate effective treatment programs. This paper discusses the pathway for activation of the HIV provirus, and proposes the use of inexpensive plant extracts to slow rates of transmission and the progression from HIV infection to AIDS. It also addresses the growing problem of HIV/tuberculosis co-infection and use of combined treatments to slow infection rates of both diseases. en
dc.language.iso en en
dc.publisher Lethbridge Undergraduate Research Journal en
dc.subject HIV Infections -- Treatment en
dc.subject HIV Infections en
dc.title Therapeutic Potential for Inhibition of HIV Activation en
dc.type Article en
dc.publisher.faculty University of Lethbridge en
dc.publisher.institution University of Lethbridge en

Files in this item

This item appears in the following Collection(s)

Show simple item record